These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11753907)

  • 1. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens.
    Hunt J; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2001 Dec; 7(12):1056-63. PubMed ID: 11753907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.
    Bahr MJ; Beckermann JG; Rifai K; Gehrmann L; Rosenau J; Klempnauer J; Strassburg CP; Manns MP
    Transplant Proc; 2005 May; 37(4):1703-4. PubMed ID: 15919437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
    Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The recurrence of hepatitic C in orthotopic liver transplantation].
    Germi MR; Pellicci R; Testa R; Ardizzone G; Lemut F; Pozzo A; Siani C
    Minerva Anestesiol; 1998; 64(1-2):29-33. PubMed ID: 9658788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study.
    Khettry U; Anand N; Faul PN; Lewis WD; Pomfret EA; Pomposelli J; Jenkins RL; Gordon FD
    Liver Transpl; 2003 Jan; 9(1):87-96. PubMed ID: 12514778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation.
    Baron PW; Sindram D; Higdon D; Howell DN; Gottfried MR; Tuttle-Newhall JE; Clavien PA
    Liver Transpl; 2000 Jul; 6(4):407-12. PubMed ID: 10915160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
    Khettry U; Huang WY; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
    Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Course of the recurrence of hepatitis C virus infection after liver transplantation].
    Gugenheim J; Baldini E; Ouzan D; Mazza D; Saint-Paul MC; Goubaux B; Mouiel J
    Gastroenterol Clin Biol; 1996; 20(10):730-5. PubMed ID: 8991141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.